4.4 Article

Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma

期刊

ONCOLOGY LETTERS
卷 8, 期 3, 页码 1249-1254

出版社

SPANDIDOS PUBL LTD
DOI: 10.3892/ol.2014.2253

关键词

hepatocellular carcinoma; mutation analysis; KRAS; cancer-related genes

类别

资金

  1. Key Research Program of the Chinese Academy of Sciences [KSZD-EW-Z-019]
  2. National Nature Science Foundation [31101261, 81302507, 81302809]
  3. Ministry of Science and Technology of China [2014AA020524]
  4. Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012KIP308, 2012KIP515]
  5. Food Safety Research Center and Key Laboratory of Food Safety Research of INS, SIBS, CAS
  6. SA-SIBS scholarship program

向作者/读者索取更多资源

The RAS/RAF and PI3K/PTEN signaling pathways play central roles in hepatocarcinogenesis. KRAS,NRAS,HRAS, BRAF, PIK3CA, PIK3RI and PTEN are key cancer-related genes in the RAS/RAF and PI3K/PTEN signaling pathways. Genetic alterations in these genes often lead to the dysregulation of the two cascades. Little is known regarding the frequency of hotspot mutations in these critical components among Chinese patients with hepatocellular carcinoma (HCC). In the current study, 57 somatic hotspot mutations in 36 HCCs samples collected from Chinese patients using direct DNA sequencing method were examined. Two cases of KRAS somatic mutations (KRAS codon 61; Gln to His) were identified among 36 HCCs (5.6%). However, no mutations were found in the NRAS,HRAS, BRAF, PIK3CA, PIK3RI and PTEN genes. These findings indicated that point mutations in the KRAS gene, but not mutations in NRAS, HRAS, BRAF, PIK3CA, PIK3RI and PTEN genes, at a somatic level contribute to the abnormal activation of the RAS/RAF and PI3K/PTEN pathways in HCC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据